Similarly, metabolomics has shown promise in expanding our understanding of other prevalent conditions, such as cardiovascular diseases (Shah et al., 2012), obesity (Chen et al., 2015)
If youre starting or already using GLP-1 therapy, we can help you understand the correct dosing schedule and ensure youre getting the most out of every injection
A large meta-analysis of 45 RCTs recently found that compared with placebo or other interventions, GLP-1RAs did not increase the risk of thyroid cancer, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass, and goiter [69]
In a Phase II trial, retatrutide demonstrated a mean weight reduction of over 17.5% in adults without diabetes but with obesity or pre-obesity, marking a significant advancement in weight management therapies
Managing your weight and understanding your caloric needs can be challenging, especially when youre taking GLP-1 medications such as Ozempic, Wegovy, Semaglutide, Mounjaro, Zepbound, Tirzepatide, Liraglutide, Saxenda, Trulicity, and Victoza